Valuation: Exosens

Market Cap 2.73B 3.04B 2.51B 2.28B 4.32B 285B 4.44B 30.11B 12B 153B 11.42B 11.18B 483B P/E 2026 *
31.8x
P/E 2027 * 23.1x
Enterprise Value 2.89B 3.22B 2.66B 2.42B 4.58B 302B 4.7B 31.87B 12.7B 162B 12.09B 11.83B 511B EV / Sales 2026 *
5.11x
EV / Sales 2027 * 4.39x
Free-Float
68.96%
Yield 2026 *
0.67%
Yield 2027 * 0.98%
1 day+0.37%
1 week-2.98%
Current month-5.45%
1 month-7.08%
3 months-14.06%
6 months-7.88%
Current year+11.04%
1 week 50.7
Extreme 50.7
55.2
1 month 50.7
Extreme 50.7
59.65
Current year 48.4
Extreme 48.4
74
1 year 40
Extreme 40
74
3 years 16.84
Extreme 16.842
74
5 years 16.84
Extreme 16.842
74
10 years 16.84
Extreme 16.842
74
Manager TitleAgeSince
Chief Executive Officer 53 01/09/2016
Director of Finance/CFO 53 01/04/2022
Chief Tech/Sci/R&D Officer - 01/07/2022
Director TitleAgeSince
Director/Board Member 53 -
Director/Board Member - -
Chairman 56 -
Date Insider Type Main position Quantity % Market Cap. Importance
14/04/26
HLD Associés SA
SellCompany 1,765,673 3.4664%
14/04/26
HLD Associés SA
SellCompany 484,327 0.9508%
23/03/26 Sell

Chief Executive Officer

45,000 0.0883%
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%-2.98%+14.71% - 3.06B
+0.65%+5.13%+8.07%+192.46% 347B
+2.11%-1.56%+12.08%+144.04% 265B
+1.09%+7.72%-1.35%+62.09% 182B
+0.77%+5.57%+14.63%+473.62% 146B
+0.87%+0.18%-10.87%-11.71% 137B
+2.26%+9.72%+1.20%+104.27% 142B
+2.43%-5.65%+33.35%+35.52% 136B
+1.65%-1.64%+5.40%+51.25% 97.69B
+0.87%-2.06%+4.19%+341.01% 85.99B
Average +1.35%+0.13%+8.14%+154.73% 154B
Weighted average by Cap. +1.38%+1.03%+7.81%+154.57%

Financials

2026 *2027 *
Net sales 565M 630M 521M 473M 896M 59.11B 921M 6.24B 2.49B 31.67B 2.37B 2.32B 100B 642M 716M 592M 537M 1.02B 67.14B 1.05B 7.09B 2.82B 35.97B 2.69B 2.63B 114B
Net income 78.47M 87.5M 72.31M 65.67M 124M 8.2B 128M 866M 345M 4.4B 328M 321M 13.89B 115M 128M 106M 95.84M 181M 11.97B 186M 1.26B 503M 6.41B 479M 469M 20.28B
Net Debt 160M 178M 147M 134M 253M 16.69B 260M 1.76B 702M 8.94B 668M 654M 28.27B 91M 101M 83.87M 76.17M 144M 9.51B 148M 1B 400M 5.1B 381M 373M 16.11B
Projected Income Statement - Annual - Exosens
Logo Exosens
Exosens specializes in the design, manufacture and marketing of high-tech electro-optical detection and imaging systems for defense and industrial applications. Under the Photonis, Telops, Xenics and El-M brands, the company offers advanced imaging cameras, electron, ion, neutron and gamma detectors, microwave amplifiers and night vision tubes, providing tailor-made solutions for highly demanding environments. At the end of 2025, the group has 12 production sites around the world. Net sales are distributed geographically as follows: France (6.7%), Greece (38.1%), Europe (33.7%), Asia (13.9%), the United States (6.1%), North America (0.9%), Oceania (0.4%), Africa (0.1%) and other (0.1%).
Employees
2,000
Date Price Change Volume
10/11/26 €53.80 +0.37% 80,953
09/11/26 €53.60 +3.78% 60,116
06/11/26 €51.65 -0.96% 90,220
05/11/26 €52.15 -3.43% 118,724
04/11/26 €54.00 -2.61% 114,064
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Exosens
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
53.60EUR
Average target price
69.85EUR
Spread / Average Target
+30.32%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Exosens
  1. Stock Market
  2. Stocks
  3. EXENS Stock